The Readout Loud cover image

246: Vas Narasimhan on the future of pharma, plus Moderna’s promise & a biotech presidential bid

The Readout Loud

00:00

What's Your Go-to Cambridge Restaurant?

Radioligin therapy is the most exciting new technology within Novartis, he says. "I think long-acting therapies that patients only need every six months or one year are going to transform healthcare over time" He lives and works in Boston but also has a home in Cambridge, Massachusetts.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app